MARKET

ITCI

ITCI

INTRA CELLULAR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.30
-0.27
-2.82%
After Hours: 9.30 0 0.00% 16:06 11/11 EST
OPEN
9.50
PREV CLOSE
9.57
HIGH
9.57
LOW
9.14
VOLUME
572.98K
TURNOVER
--
52 WEEK HIGH
18.32
52 WEEK LOW
6.75
MARKET CAP
513.93M
P/E (TTM)
-3.4614
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ITCI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ITCI News

  • Top Ranked Momentum Stocks to Buy for November 11th
  • Zacks.8h ago
  • Hedge Funds Have Never Been Less Bullish On Intra-Cellular Therapies Inc (ITCI)
  • Insider Monkey.2d ago
  • Intra-Cellular Therapies, Inc. (ITCI) CEO Sharon Mates on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.6d ago
  • Intra-Cellular Therapies EPS beats by $0.18
  • seekingalpha.6d ago

More

Industry

Biotechnology & Medical Research
-0.51%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About ITCI

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company is discovering and developing drugs for the treatment of neurological and psychiatric disorders. Lumateperone (also known as ITI-007) is its lead product candidate. The Company's bipolar depression program consists of two Phase III multi-center, randomized, double-blind, placebo-controlled clinical trials: one to evaluate lumateperone as a monotherapy and the other to evaluate lumateperone as an adjunctive therapy with lithium or valproate. The Company initiated Phase III development of lumateperone for the treatment of agitation in patients with dementia, including Alzheimer's Disease (AD).
More

Webull offers Intra-Cellular Therapies Inc (ITCI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.